| AZT | aztreonam |
| BL/BLI | β-lactam/β-lactamase inhibitor |
| BCT | Blue Carba Test |
| CDT | combination disc testing |
| cIAI | complicated intra-abdominal infection |
| CIM | carbapenem inactivation method |
| CR-GNB | carbapenem-resistant Gram-negative bacteria |
| C/T | ceftolozane/tazobactam |
| cUTI | complicated urinary tract infection |
| CZA | ceftazidime/avibactam |
| eCIM | EDTA-based CIM |
| ESBL | extended-spectrum-β-lactamase |
| FICI | fractional inhibitory concentration index |
| HAP | hospital-acquired pneumonia |
| IMR | imipenem/relebactam |
| IMP | imipenemase |
| KPC | Klebsiella pneumoniae carbapenemase |
| MBL | metallo-β-lactamase |
| mCIM | modified CIM test |
| MEV | meropenem/vaborbactam |
| MIC | minimum inhibitory concentration |
| NDM | New Delhi metallo-β-lactamase |
| OXA | oxacillinase |
| VAP | ventilator-associated pneumonia |
| VIM | Verona integron-mediated metallo-β-lactamase |
| XDR | extensive drug-resistant |